The trial is registered as "Not yet recruiting" at ClinicalTrials.gov. The estimated start was 2025-10.
A newsletter dated 2025-11-06 and signed by Douglas Hartley, Chief Medical Officer at Rinri Therapeutics, states:
Rinri Therapeutics webiste elaborates:
They're still game, but will take...